189 related articles for article (PubMed ID: 23894305)
21. DNA methyltransferase 1 drives transcriptional down-modulation of β catenin antagonist Chibby1 associated with the BCR-ABL1 gene of chronic myeloid leukemia.
Leo E; Mancini M; Castagnetti F; Gugliotta G; Santucci MA; Martinelli G
J Cell Biochem; 2015 Apr; 116(4):589-97. PubMed ID: 25389112
[TBL] [Abstract][Full Text] [Related]
22. Homeobox A9 directly targeted by miR-196b regulates aggressiveness through nuclear Factor-kappa B activity in non-small cell lung cancer cells.
Yu SL; Lee DC; Sohn HA; Lee SY; Jeon HS; Lee JH; Park CG; Lee HY; Yeom YI; Son JW; Yoon YS; Kang J
Mol Carcinog; 2016 Dec; 55(12):1915-1926. PubMed ID: 26586336
[TBL] [Abstract][Full Text] [Related]
23. Deregulated expression of Cdc6 as BCR/ABL-dependent survival factor in chronic myeloid leukemia cells.
Zhang JH; He YL; Zhu R; Du W; Xiao JH
Tumour Biol; 2017 Jun; 39(6):1010428317713394. PubMed ID: 28639894
[TBL] [Abstract][Full Text] [Related]
24. miR-217 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitors by targeting pro-oncogenic anterior gradient 2.
Pan B; Yang J; Wang X; Xu K; Ikezoe T
Exp Hematol; 2018 Dec; 68():80-88.e2. PubMed ID: 30195077
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of miR-199b associated with imatinib drug resistance in 9q34.1 deleted BCR/ABL positive CML patients.
Joshi D; Chandrakala S; Korgaonkar S; Ghosh K; Vundinti BR
Gene; 2014 Jun; 542(2):109-12. PubMed ID: 24680705
[TBL] [Abstract][Full Text] [Related]
26. Linking miRNA regulation to BCR-ABL expression: the next dimension.
Faber J; Gregory RI; Armstrong SA
Cancer Cell; 2008 Jun; 13(6):467-9. PubMed ID: 18538729
[TBL] [Abstract][Full Text] [Related]
27. MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR-ABL protein.
Hershkovitz-Rokah O; Modai S; Pasmanik-Chor M; Toren A; Shomron N; Raanani P; Shpilberg O; Granot G
Cancer Lett; 2015 Jan; 356(2 Pt B):597-605. PubMed ID: 25305453
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-582-3p negatively regulates cell proliferation and cell cycle progression in acute myeloid leukemia by targeting cyclin B2.
Li H; Tian X; Wang P; Huang M; Xu R; Nie T
Cell Mol Biol Lett; 2019; 24():66. PubMed ID: 31844417
[TBL] [Abstract][Full Text] [Related]
29. [microRNA targeted to chronic myeloid leukemia Bcr-Abl oncogene screen using deacetylase inhibitor].
Ai ZD; Wu HY; Chen L
Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(1):46-50. PubMed ID: 29343029
[No Abstract] [Full Text] [Related]
30. MXD1 regulates the imatinib resistance of chronic myeloid leukemia cells by repressing BCR-ABL1 expression.
Huan C; Jin L; Heng W; Na A; Yuming P; Xin D; Qiaoxia Z
Leuk Res; 2018 Dec; 75():1-6. PubMed ID: 30419548
[TBL] [Abstract][Full Text] [Related]
31. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
[TBL] [Abstract][Full Text] [Related]
32. Differential Regulation of Telomeric Complex by
Deregowska A; Pepek M; Pruszczyk K; Machnicki MM; Wnuk M; Stoklosa T
Genes (Basel); 2020 Sep; 11(10):. PubMed ID: 33003326
[TBL] [Abstract][Full Text] [Related]
33. Restoration of miR-424 suppresses BCR-ABL activity and sensitizes CML cells to imatinib treatment.
Hershkovitz-Rokah O; Modai S; Pasmanik-Chor M; Toren A; Shomron N; Raanani P; Shpilberg O; Granot G
Cancer Lett; 2015 May; 360(2):245-56. PubMed ID: 25697481
[TBL] [Abstract][Full Text] [Related]
34. DNA hypermethylation promotes the low expression of pro-apoptotic BCL2L11 associated with BCR-ABL1 fusion gene of chronic myeloid leukaemia.
Leo E; Mancini M; Aluigi M; Castagnetti F; Martinelli G; Barbieri E; Santucci MA
Br J Haematol; 2012 Nov; 159(3):373-6. PubMed ID: 22924699
[No Abstract] [Full Text] [Related]
35. Acute monocytic leukemia with coexpression of minor BCR-ABL1 and PICALM-MLLT10 fusion genes along with overexpression of HOXA9.
Sindt A; Deau B; Brahim W; Staal A; Visanica S; Villarese P; Rault JP; Macintyre E; Delabesse E
Genes Chromosomes Cancer; 2006 Jun; 45(6):575-82. PubMed ID: 16518848
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic regulation of miR-196b expression in gastric cancer.
Tsai KW; Hu LY; Wu CW; Li SC; Lai CH; Kao HW; Fang WL; Lin WC
Genes Chromosomes Cancer; 2010 Nov; 49(11):969-80. PubMed ID: 20662076
[TBL] [Abstract][Full Text] [Related]
37. miR-146b-5p within BCR-ABL1-Positive Microvesicles Promotes Leukemic Transformation of Hematopoietic Cells.
Zhang HM; Li Q; Zhu X; Liu W; Hu H; Liu T; Cheng F; You Y; Zhong Z; Zou P; Li Q; Chen Z; Guo AY
Cancer Res; 2016 May; 76(10):2901-11. PubMed ID: 27013199
[TBL] [Abstract][Full Text] [Related]
38. HOXA9 gene expression in the chronic myeloid leukemia progression.
Tedeschi FA; Zalazar FE
Leuk Res; 2006 Nov; 30(11):1453-6. PubMed ID: 16630659
[TBL] [Abstract][Full Text] [Related]
39. DNA methylation-mediated differential expression of DLX4 isoforms has opposing roles in leukemogenesis.
Zhou JD; Zhao YJ; Leng JY; Gu Y; Xu ZJ; Ma JC; Wen XM; Lin J; Zhang TJ; Qian J
Cell Mol Biol Lett; 2022 Jul; 27(1):59. PubMed ID: 35883028
[TBL] [Abstract][Full Text] [Related]
40. MicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemia.
Chakraborty C; Sharma AR; Patra BC; Bhattacharya M; Sharma G; Lee SS
Oncotarget; 2016 Jul; 7(27):42683-42697. PubMed ID: 26967056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
